Lars Olaf C.
- Country
- Sweden
- Department
- Karolinska Universitetssjukhuset Solna Öron, Näs och halsmottagningen
Research Overview
- Long‑Term Safety and Tolerability of Subcutaneous Itepekimab in Adults with Inadequately Controlled Chronic Rhinosinusitis with Nasal Polyps: Double‑Blind Extension Study
- Evaluation of Intralymphatic Immunotherapy Enhanced by Vitamin D in Patients with Moderate to Severe Allergic Rhinitis: A Randomized, Placebo-Controlled Study
- Phase 3 Evaluation of Itepekimab Efficacy and Safety in Adults with Inadequately-Controlled Chronic Rhinosinusitis with Nasal Polyps
Data & Insights
Has run more than one trial at 36 of 91 partner sites.
Specializations
Autoimmune & Inflammatory Disorders
Focused on complex immune‑mediated conditions affecting skin, joints, and internal organs.
- systemic lupus erythematosus
- cutaneous lupus erythematosus
- ANCA-associated vasculitis
- rheumatoid arthritis
- immune thrombocytopenia
Research integrates targeted biologics and novel immunomodulators to modify disease pathways.
Hematologic Malignancies
Investigation of lymphoid and myeloid cancers across pediatric and adult populations.
- acute lymphoblastic leukemia
- acute myeloid leukemia
- chronic lymphocytic leukemia
- multiple myeloma
- diffuse large B‑cell lymphoma
Efforts emphasize molecular profiling and immunotherapeutic strategies.
Solid Tumor Oncology
Broad engagement with malignant neoplasms of the lung, breast, gastrointestinal tract, and urogenital system.
- non‑small cell lung cancer
- breast carcinoma
- colorectal cancer
- renal cell carcinoma
- pancreatic ductal adenocarcinoma
Clinical work explores targeted agents, checkpoint inhibition, and combination regimens.
Neurodegenerative & Neurological Diseases
Specialized interest in disorders of the central nervous system and neuromuscular function.
- Alzheimer’s disease
- multiple sclerosis
- amyotrophic lateral sclerosis
- frontotemporal dementia
- glioblastoma
Studies aim to identify disease‑modifying therapies and biomarkers of progression.
Cardiovascular & Metabolic Disorders
Attention to atherosclerotic disease, heart failure, and metabolic dysregulation.
- atherosclerotic cardiovascular disease
- heart failure
- atrial fibrillation
- type 2 diabetes mellitus
- hypertriglyceridemia
Research incorporates novel lipid‑lowering agents and precision‑medicine approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.